Avitene 1010020Recalls & reported problems
Davol Inc. · Avitene Flour, 1.0 gram · Class 3 · Implant
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00801741000386), received between Jul 12, 2017 and Jun 9, 2025 — classified as 4 injuries, 3 malfunctions.
The most frequently reported specific device problem is “Device Contamination with Chemical or Other Material” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- Device Contamination with Chemical or Other Material3
- Patient-Device Incompatibility3
- Off-Label Use1
Patient problems
- Necrosis2
- No Clinical Signs, Symptoms or Conditions2
- Granuloma1
- Intervertebral Disc Compression or Protrusion1
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryJun 9, 2025Patient-Device Incompatibility; Patient-Device Incompatibility
AS REPORTED, THE PATIENT UNDERWENT A PROCEDURE WITH USAGE OF AVITENE, AFTER WHICH A GRANULOMA WAS FOUND. CLEANING WAS PERFORMED AFTER PLACING THE AVITENE AND HEMOSTASIS ACHIEVED. IT WAS REPORTED THAT THE PATIENT IS CURRENTLY BEING TREATED.
Patient problems: Granuloma
MAUDE report 22168198 ↗MalfunctionDec 23, 2024Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
AS REPORTED, A BLACK FOREIGN OBJECT WAS FOUND IN THE AVITENE IN AN UNOPENED STATE BEFORE USE. IT WAS REPORTED THAT THERE WAS NO SIGN OF PACKAGE DAMAGE FOUND. THERE WAS NO PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21000994 ↗InjuryJun 12, 2024Patient-Device Incompatibility; Patient-Device Incompatibility
PER MEDWATCH REPORT (MW5154685): ON OR ABOUT (B)(6) 2020 A DEPUY SPINAL WAS USED IN PATIENT SURGERY. UPON INFORMATION, THE PRODUCT USED IN PATIENT SURGERY INCLUDE DEPUY EXPEDIUM, COBALT CHROMIUM RODS, UNIAXIAL PEDICEL SCREWS, DEPUY SPINE SCREWS, ROD VIPER STRAIGHT AND OR OTHER ASSOCIATED DEVICES. THE PATIENT HAD SOME PAIN POSTOPERATIVELY AND ALSO HAD DESCRIPTIONS OF CRACKING AND POPPING INVOLVING HER LUMBOSACRAL SPINE. X-RAY REVEALED A DISENGAGEMENT OF THE LEFT-SIDED ROD FROM HER L3 PEDICLE SCREW AND THE PATIENT'S CORONAL BALANCE ALSO APPEARED TO BE SIGNIFICANTLY AFFECTED. PATIENT WAS CAUSED TO SUSTAIN SEVERE, SERIOUS, PERMANENT INJURIES THAT HAD RENDERED HER SICK LORE, LAME AND DISABLED. ALSO NOTED THE PATIENT EXPERIENCED NECROSIS. ON (B)(6) 2020 THE PATIENT UNDERWENT REINSERTION OF SPINAL FIXATION DEVICE WITH REVISION OF INSTRUMENTATION DUE TO POSTERIOR INSTRUMENTED SPINAL FUSION HARDWARE FAILURE. ON (B)(6) 2020 THE PATIENT UNDERWENT EXCISIONAL DEBRIDEMENT OF SKIN INCLUDING THE SUBCUTANEOUS LEVEL AND FASCIA, RIGHT SIDE AND LEFT SIDE. "THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2)." NOTE: THE COMPLAINT REPORTED FAILURE OF SPINAL I
Patient problems: Necrosis
MAUDE report 19520170 ↗InjuryJun 12, 2024Patient-Device Incompatibility; Patient-Device Incompatibility
PER MEDWATCH REPORT (MW5154686): ON OR ABOUT (B)(6) 2020 A DEPUY SPINAL WAS USED IN PATIENT SURGERY. UPON INFORMATION, THE PRODUCT USED IN PATIENT SURGERY INCLUDE DEPUY EXPEDIUM, COBALT CHROMIUM RODS, UNIAXIAL PEDICEL SCREWS, DEPUY SPINE SCREWS, ROD VIPER STRAIGHT AND OR OTHER ASSOCIATED DEVICES. THE PATIENT HAD SOME PAIN POSTOPERATIVELY AND ALSO HAD DESCRIPTIONS OF CRACKING AND POPPING INVOLVING HER LUMBOSACRAL SPINE. X-RAY REVEALED A DISENGAGEMENT OF THE LEFT-SIDED ROD FROM HER L3 PEDICLE SCREW AND THE PATIENT'S CORONAL BALANCE ALSO APPEARED TO BE SIGNIFICANTLY AFFECTED. PATIENT WAS CAUSED TO SUSTAIN SEVERE, SERIOUS, PERMANENT INJURIES THAT HAD RENDERED HER SICK LORE, LAME AND DISABLED. ALSO NOTED THE PATIENT EXPERIENCED NECROSIS. ON (B)(6) 2020 THE PATIENT UNDERWENT REINSERTION OF SPINAL FIXATION DEVICE WITH REVISION OF INSTRUMENTATION DUE TO POSTERIOR INSTRUMENTED SPINAL FUSION HARDWARE FAILURE. ON (B)(6) 2020 THE PATIENT UNDERWENT EXCISIONAL DEBRIDEMENT OF SKIN INCLUDING THE SUBCUTANEOUS LEVEL AND FASCIA, RIGHT SIDE AND LEFT SIDE. "THIS REPORT REFLECTS INFORMATION RECEIVED BY FDA IN THE FORM OF A NOTIFICATION PER 803.22 (B)(2)". REFERENCE REPORT MW5154685. NOTE: THE COMPLAINT
Patient problems: Necrosis
MAUDE report 19520166 ↗InjuryDec 8, 2023Off-Label Use; Off-Label Use
AS REPORTED, THE PATIENT UNDERWENT THE ANTERIOR CERVICAL DISCECTOMY AND FUSION (ACDF) PROCEDURE ON (B)(6) 2023. AVITENE FLOUR 1 GRAM MIXED WITH SALINE AND THROMBIN WAS USED (OFF LABEL PER IFU). THE SURGEON LEFT EXCESS AVITENE IN AND SEEPED INTO THE EPIDURAL SPACE LEADING TO SPINAL CORD COMPRESSION. POST USAGE PATIENT EXPERIENCED PAIN AND WEAKNESS IN ARM AND UNDERWENT ADDITIONAL SURGERY ON (B)(6) 2023 WHICH INCLUDED A CORPECTOMY. NO OTHER HEMOSTATIC AGENTS OR PRODUCTS WERE USED.
Patient problems: Intervertebral Disc Compression or Protrusion
MAUDE report 18291237 ↗MalfunctionMay 7, 2022Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
AS REPORTED, DURING AN UNKNOWN PROCEDURE ON (B)(6) 2022, DURING PREPARATION OF THE BARD/DAVOL AVITENE FLOUR WITH SALINE SOLUTION, A HAIR-LIKE FOREIGN MATERIAL WAS FOUND. THERE WAS NO DAMAGE NOTICED ON THE OUTER PACKAGE. THERE WAS NO REPORTED PATIENT INJURY.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14318401 ↗MalfunctionJul 12, 2017Device Contamination with Chemical or Other Material; Device Contamination with Chemical or Other Material
IT WAS REPORTED THAT WHEN THE MEDICAL STAFF OPENED THE TRAY OF BARD AVITENE FLOUR, A PIECE OF FOREIGN MATTER WAS NOTED TO BE IN THE FLOUR. UPON RECEIPT OF THE SAMPLE IT WAS NOTED THAT THE FOREIGN MATERIAL WAS A SMALL METAL FRAGMENT. THIS FRAGMENT COULD PRESENT AS A HARM TO THE PATIENT IF IT HAD GONE UNDETECTED OR HAD BEEN LEFT IN THE PATIENT FOLLOWING USE OF THE PRODUCT. THEREFORE THIS MDR IS FILED TO DOCUMENT THIS EVENT.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 6706739 ↗
Other Agent, absorbable hemostatic, collagen based devices
- SURGIFLO® Hemostatic Matrix Kit with Thrombin 2994Ferrosan Medical Devices A/S · Agent, Absorbable Hemostatic, Collagen Based1 recall42 reports
- SURGIFOAM® Absorbable Gelatin Powder Kit 1979Ferrosan Medical Devices A/S · Agent, Absorbable Hemostatic, Collagen Based1 recall2 reports
- Avitene 1050030Davol Inc. · Agent, absorbable hemostatic, collagen based1 recall1 report
- SURGIFOAM® Absorbable Gelatin Sponge, U.S.P. 1972Ferrosan Medical Devices A/S · Agent, Absorbable Hemostatic, Collagen Based24 reports
- SURGIFLO® Hemostatic Matrix 2991Ferrosan Medical Devices A/S · Agent, Absorbable Hemostatic, Collagen Based17 reports
- Avitene 1010090Davol Inc. · Agent, absorbable hemostatic, collagen based7 reports
- SURGIFLO™ Hemostatic Matrix Kit with Thrombin SF2995Ferrosan Medical Devices A/S · Agent, Absorbable Hemostatic, Collagen Based4 reports
- Avitene 1020010Davol Inc. · Agent, absorbable hemostatic, collagen based3 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page